EDGAR Filing Documents for 0001144204-17-064823

Form 8-K - Current report:

SEC Accession No. 0001144204-17-064823

Filing Date

2017-12-21

Accepted

2017-12-21 17:17:58

Documents

Period of Report

2017-12-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tv481767_8k.htm	8-K	26915
2	EXHIBIT 4.1	tv481767_ex4-1.htm	EX-4.1	71418
3	EXHIBIT 4.2	tv481767_ex4-2.htm	EX-4.2	71791
4	EXHIBIT 4.3	tv481767_ex4-3.htm	EX-4.3	131215
	Complete submission text file	0001144204-17-064823.txt		302812

Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121

Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100

Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)